COVID-19: Pfizer withdraws emergency use application for its vaccine in India



The US company, which was the first drugmaker to apply for emergency use authorization of its COVID-19 vaccine in India, had a meeting with the country`s drugs regulator on Wednesday and the decision was made after that, the company said.